This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignee: Conopco, Inc.. Active years: 2013-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2022
Title: **The Innovations of Ganesh Chandramowli in Bengaluru**
Introduction
Ganesh Chandramowli is an inventive force based in Bengaluru, India, known for his remarkable contributions to the field of biochemistry and dermatology. With a total of four patents to his name, he has made significant strides in developing compounds aimed at enhancing skin health and pigmentation.
Latest Patents
Ganesh’s latest patents showcase his expertise in the formulation of peptides and inhibitors that target melanocytes to increase melanin production and treat hyperpigmentation. One of his notable inventions involves the use of a specific compound formula designed to enhance melanin levels in melanocytes, which can greatly benefit individuals seeking solutions for skin pigmentation issues. Furthermore, he has developed a series of tyrosinase inhibitors that inhibit the activity of human tyrosinase in skin applications, providing a mechanism to tackle hyperpigmentation effectively.
Career Highlights
Currently working at Conopco, Inc., Ganesh has established himself as a leading inventor in his field. His work involves rigorous research and development to innovate skincare solutions that address common dermatological concerns. His patents reflect his commitment to improving skin health and offer potential benefits to consumers worldwide.
Collaborations
Ganesh collaborates with talented professionals like Sreenivasa Thimmaiah and Babu Rakesh Kumar Bandi, who contribute their expertise to enhance the research and development processes. Together, they strive to push the boundaries of innovation in the skincare industry.
Conclusion
Ganesh Chandramowli’s innovative spirit and dedication to his work have resulted in significant advancements in the field of dermatology. His patents not only demonstrate his ingenuity but also hold the promise of transforming skincare treatments for many. As he continues his work at Conopco, Inc., the potential for future innovations remains bright.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
